-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-virus-infection-screening-nonpregnant-adolescents-adults-may-2014
June 18, 2014 - Biopsy is sometimes done to determine the extent of liver inflammation and fibrosis 1 . … adequate duration and power to evaluate long-term health outcomes (for example, cirrhosis, end-stage liver … This fair-quality study enrolled 651 patients with advanced liver disease who were randomly assigned … Lamivudine for patients with chronic hepatitis B and advanced liver disease. … Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C.
-
hcup-us.ahrq.gov/toolssoftware/comorbidity/Table2-FY12-V3_7.pdf
February 01, 2017 - Liver disease 070.22, 070.23,
070.32, 070.33 ,
070.44, 070.54,
456.0, 456.1,
456.20, 456.21,
571.0 … , 571.2,
571.3, 571.40-
571.49, 571.5,
571.6, 571.8,
571.9, 572.3,
572.8, 573.5,
V42.7
Liver: … 199-202,
205-208
Liver: 420-425,
432-434, 441-446
Liver: 420-425,
432-434, 441-446
Liver: 420 … -425,
432-434, 441-446
Liver: 420-425,
432-434, 441-446
Liver: 420-425,
432-434, 441-446
No
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
October 01, 2010 - . ���
Liver transplantation* No effect on mortality, OR time, or ICU length of stay. ���
Possible reduction … Medical Conditions
�� Cancer-related conditions.
�� Gastrointestinal bleeding not related to liver … disease.
�� Hematopoietic stem cell transplantation.
�� Liver disease (other than transplantation).
-
effectivehealthcare.ahrq.gov/sites/default/files/mcda-johnson.pdf
August 27, 2012 - Image: Bar chart showing 3 month, 5-month, and 10-month progression-free survival
rates and chance of liver … Image: Bar chart showing 3 month, 5-month, and 10-month progression-free survival
rates and chance of liver … Image: Bar chart showing 3 month, 5-month, and 10-month progression-free survival
rates and chance of liver … another dashed line from 0.0% to 2.0% with an arrow pointing downward on
the 2.0 bar on the chance of liver
-
hcup-us.ahrq.gov/toolssoftware/comorbidity/comformat2010.txt
October 20, 2015 - "5716 ",
"5718 ",
"5719 ",
"5723 ",
"5728 ",
"V427 " = "LIVER … " /* Liver disease */
"53141",
"53151",
"53161",
"53170",
"53171" … /dialysis */
652, 682-685
= "YES" ;
VALUE LIVERDRG /* Liver
-
hcup-us.ahrq.gov/toolssoftware/comorbidity/comformat2011.txt
October 20, 2015 - "5716 ",
"5718 ",
"5719 ",
"5723 ",
"5728 ",
"V427 " = "LIVER … " /* Liver disease */
"53141",
"53151",
"53161",
"53170",
"53171" … /dialysis */
652, 682-685
= "YES" ;
VALUE LIVERDRG /* Liver
-
hcup-us.ahrq.gov/toolssoftware/comorbidity/comformat2009.txt
October 20, 2015 - "5716 ",
"5718 ",
"5719 ",
"5723 ",
"5728 ",
"V427 " = "LIVER … " /* Liver disease */
"53141",
"53151",
"53161",
"53170",
"53171" … /dialysis */
652, 682-685
= "YES" ;
VALUE LIVERDRG /* Liver
-
hcup-us.ahrq.gov/toolssoftware/comorbidity/comformat2008_v25.txt
October 20, 2015 - "5716 ",
"5718 ",
"5719 ",
"5723 ",
"5728 ",
"V427 " = "LIVER … " /* Liver disease */
"53141",
"53151",
"53161",
"53170",
"53171" … /dialysis */
652, 682-685
= "YES" ;
VALUE LIVERDRG /* Liver
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_executive.pdf
September 01, 2014 - liver metastases:
Sensitivity: 72.0% to
97.9%
Table A. … transplantation, or individuals with
chronic liver disease. … For detecting colorectal liver metastases, MRI is superior
to CT. … Moderate-strength
evidence suggests MRI is superior to CT for detecting
colorectal liver metastases … Preoperative staging of
patients with liver metastases of colorectal carcinoma.
-
hcup-us.ahrq.gov/db/vars/cm_liver/nisnote.jsp
September 01, 2008 - Description of Data Elements
CM_LIVER - AHRQ comorbidity measure for ICD-9-CM codes: liver … Variable Description Value Value Description CM_LIVER AHRQ comorbidity measure for ICD-9-CM codes: liver
-
hcup-us.ahrq.gov/db/vars/cm_liver/nrdnote.jsp
August 01, 2015 - Description of Data Elements
CM_LIVER - AHRQ comorbidity measure for ICD-9-CM codes: liver … Variable Description Value Value Description CM_LIVER AHRQ comorbidity measure for ICD-9-CM codes: liver
-
hcup-us.ahrq.gov/db/vars/cm_liver/kidnote.jsp
September 01, 2008 - Description of Data Elements
CM_LIVER - AHRQ comorbidity measure for ICD-9-CM codes: liver … Variable Description Value Value Description CM_LIVER AHRQ comorbidity measure for ICD-9-CM codes: liver
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-260-improved-cancer-outcomes-disposition-comments.pdf
May 22, 2023 - For
example, for non-alcoholic fatty liver disease-
indiced liver fibrosis, some clinical reviewers … are
very narrow-minded in insisting that
dietary/lifestyle interventions propose/implement
liver biopsy-based … confirmation of NASH or liver
fibrosis before and after (and in the middle if long-
term) the interventions … There are sensitive
imaging (MRI, MRE) methods for liver
fat/steatosis and liver stiffness/fibrosis … that have
been validated against liver biopsy with excellent
performance but some clinical reviewers
-
cds.ahrq.gov/sites/default/files/workgroups/241/jun-2017-cholesterol-wg-notes.docx
January 01, 2017 - .
· Alternately, one organization does not list specific liver conditions. … > 3 x’s the normal limit)
· Some studies have shown that patients with Hep B do fine on statins.
· Liver … Disease
· Liver disease is very complicated.
-
hcup-us.ahrq.gov/reports/statbriefs/sb303-Comorbidities-Adult-Hospitalizations-2019.pdf
January 01, 2019 - included in multiple comorbidity categories with the following exceptions: hypertension, diabetes, liver … for kidney disease and failure are divided into moderate and severe,
respectively; and the bars for liver … If a stay had an
indication of both mild disease and moderate to severe liver disease and failure, it … Liver disorders include mild forms of liver disease (e.g., alcoholic fatty liver, toxic liver
disease … , hepatic fibrosis, infarction of the liver, unspecified liver disease) and moderate to severe liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
April 01, 2013 - disease, including cirrhosis, liver failure, and hepatocellular cancer. … disease or elevated liver function test. … biopsy vs. those
selected for treatment
without undergoing a liver
biopsy? … Liver biopsy
vs. … Treatment of patients with HCV infection
with or without liver biopsy.
-
psnet.ahrq.gov/node/851071/psn-pdf
June 28, 2023 - This report describes the
errors that contributed to failed transplants and patient deaths at one liver
-
hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/CMR-User-Guide-v2025-1.pdf
November 01, 2024 - CMR_LIVER_MLD: Liver
disease, mild
• Under ICD-9-CM there was one comorbidity measure for Liver … disease (LIVER). … to severe
liver disease and failure … measure for Liver
disease (LIVER). … to severe
liver disease and failure
-
hcup-us.ahrq.gov/toolssoftware/comorbidity/comformat2012-2015.txt
January 01, 2015 - "5718 ",
"5719 ",
"5723 ",
"5728 ",
"5735 ",
"V427 " = "LIVER … " /* Liver disease */
"53141",
"53151",
"53161",
"53170",
"53171" … /dialysis */
652, 682-685
= "YES" ;
VALUE LIVERDRG /* Liver
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
January 24, 2022 - 109 (80.7)
Moderate+severe: 26 (19.3)
Becchetti 2021 Humoral response to SARS-CoV-2 infection among liver … transplant recipients 34987065 Humoral response to SARS-CoV-2 infection among liver transplant recipients … Switzerland
Belgium
Italy
The Netherlands Prospective case-control 2 Solid-organ transplant Adult liver … ICU: 0 (0)
Caballero-Marcos 2021 Changes in humoral immune response after SARS-CoV-2 infection in liver … immunocompetent patients 33835707 Changes in humoral immune response after SARS-CoV-2 infection in liver